Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Neogenin ELISA Kit (AC2637)
Cat.#: ASET-1226
Specifications
Description Human Neogenin ELISA Kit allows for the in vitro quantitative determination of human Neogenin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2357 Human GBA ELISA Kit (AC3768) Quantitative inquiry ASET-1141 Human Dio3 ELISA Kit (AC2552) Quantitative inquiry ASET-1412 Human UNC5D ELISA Kit (AC2823) Quantitative inquiry ASET-2505 Rat Luteinizing Hormone ELISA Kit (AC3916) Quantitative inquiry ASET-1884 Human LMX1b ELISA Kit (AC3295) Quantitative inquiry ASET-2218 Human POMT1 ELISA Kit (AC3629) Quantitative inquiry ASET-2315 Mouse TSH ELISA Kit (AC3726) Quantitative inquiry ASET-1687 Mouse Neogenin ELISA Kit (AC3098) Quantitative inquiry ASET-1352 Rabbit Apolipoprotein E ELISA Kit (AC2763) Quantitative inquiry ASET-1089 Human Profilin 1 ELISA Kit (AC2500) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket